Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
University of Mississippi Medical Center, Jackson, Mississippi, United States
West China Hospital of Sichuan University, Department of Anesthesiology, Chengdu, Sichuan, China
Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States
Department of Anesthesiology Koege Hospital, Koege, Denmark
Asklepieion General Hospital, Athens, Voula, Greece
Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of
Orlando Orthopaedic Center, Orlando, Florida, United States
Regina Elena CI, Rome, Italy
Women's College Hospital, Toronto, Ontario, Canada
Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.